David F Cella
Northwestern University · 1,830 works · 149,700 citations · h-index 183
Top works
- The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
- Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
- Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
- Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument
- The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
- The Patient-Reported Outcomes Measurement Information System (PROMIS)
- Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations
- Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system
- Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial
- What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?Results from Eastern Cooperative Oncology Group (ECOG) Study 5592
- Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
- Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- Effect of Cancer on Quality of Life
- Measuring quality of life today: methodological aspects.
- Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrument
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales
- Psychometric Evaluation and Calibration of Health-Related Quality of Life Item Banks